RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
 ALNY | Alnylam Pharmaceuticals, Inc. | $29.4b | $226.50 | +1.6% | 1.2M |
 ARWR | Arrowhead Research Corporation | $9.1b | $58.16 | +1.6% | 777.3K |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $7.2b | $43.08 | +1.1% | 1.6M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $0.7b | $3.21 | +1.4% | 2.7M |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $251.0m | $3.38 | -2.7% | 46.9K |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $230.7m | $1.25 | -4.3% | 912.3K |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $222.7m | $6.28 | +1.6% | 92.9K |
 RNA | Atrium Therapeutics, Inc. Common Stock | $134.1m | $8.04 | -2.1% | 164.8K |
 ELOX | Eloxx Pharmaceuticals, Inc. Common Stock | $42.0m | $13.16 | 0.0% | 26.6K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $11.4m | $0.91 | +0.1% | 41.8K |
 XCUR | Exicure, Inc. Common Stock | $7.5m | $1.07 | +1.0% | 35.5K |